• KAFM
  • Contact us
  • E-Submission
ABOUT
ARTICLE CATEGORY
BROWSE ARTICLES
AUTHOR INFORMATION

Page Path

1
results for

"Juyoung Shin"

Filter

Article category

Keywords

Publication year

"Juyoung Shin"

Review Article
Increasing Individual Target Glucose Levels to Prevent Hypoglycemia in Patients with Diabetes
Juyoung Shin, Hyunah Kim, Hun-Sung Kim, Churlmin Kim, Whan-Seok Choi
Korean J Fam Med 2021;42(4):269-273.   Published online January 29, 2020
DOI: https://doi.org/10.4082/kjfm.19.0161
Hypoglycemia is one of the severe complications of diabetes. To prevent hypoglycemia, an emphasis is placed on maintaining an appropriate balance between nutrition, activity, and treatment, which can be achieved by the repetition of self-trials based on self-monitoring. Clinicians routinely focus on patients’ contribution, including timely intake of an adequate amount of carbohydrates, physical activity, antidiabetic medication, and abstinence from alcohol. Recently, many guidelines have highlighted the importance of clinicians’ factors and recommend individualized treatments according to lifestyle patterns and specific needs following the de-intensification of treatment. The optimal value of hemoglobin A1c (HbA1c) levels for blood glucose level regulation remains controversial among countries, but it generally does not exceed 8.0%. In populations that are at a risk of hypoglycemia, such as the older adults, it is advisable to adjust the target blood glucose level to less than 8.0%. Meanwhile, a blood glucose level of 7.0%–7.5% is generally recommended for healthy older adults. If the expected lifetime is shorter than 10 years or in patients with chronic kidney disease and severe cardiovascular disease, the HbA1c level target can be increased to 7.5%–8.0%. For even shorter lifetime expectancy, the target can be adjusted up to 8.0%–9.0%. To prevent hypoglycemia, the target blood glucose level needs to be adjusted, particularly in older adult patients. Ultimately, it is important to identify the maximum blood glucose levels that do not cause hypoglycemia and the minimum blood glucose levels that do not cause hyperglycemia-associated complications.

Citations

Citations to this article as recorded by  
  • Initiating an Insulin Safety Campaign to reduce the incidence of glycemic harm events for hospitalized adults 65 and older
    Michelle Cohen, Kristen de Grandpre, William M. Herlihy, Lise Cooper
    Journal of the American Geriatrics Society.2025; 73(2): 602.     CrossRef
  • Hyperglycaemia aversion in type 1 diabetes: A grounded theory study
    Vicky McKechnie, Nick Oliver, Stephanie A. Amiel, John R. E. Fox
    British Journal of Health Psychology.2024; 29(1): 254.     CrossRef
  • Review—Glucose Monitoring Sensors: History, Principle, and Challenges
    Yanzhen Jing, Shwu Jen Chang, Ching-Jung Chen, Jen-Tsai Liu
    Journal of The Electrochemical Society.2022; 169(5): 057514.     CrossRef
  • 12,426 View
  • 159 Download
  • 3 Web of Science
  • 3 Crossref
TOP